Disinfection Lighting for Occupied Space
Air and Surface UV LED Solutions
Leveraging decades of UV and LED experience to develop solutions for continuous disinfection of occupied spaces to help reduce exposure to surface bacteria and airborne viruses.
Different Solutions for Different Needs

Air Disinfection
UVC solutions can help reduce viruses in air. Based on testing using a bacteriophage MS2 model system, Current predicts that 365DisInFx™ UVC technology will provide 99% inactivation with less than 6 hours of exposure for seasonal coronaviruses, including SARS-CoV-2, the virus that is known to cause COVID-19, when used as directed.1

Surface Disinfection
UVA solutions can help reduce bacteria and fungi on surfaces. Our in vitro testing with eight hours of exposure has shown significant reductions in common pathogens associated with hospital-acquired infections (HAIs), such as MRSA, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Candida albicans and auris.2
Explore the products.
* If combining two or more UV solutions, please consult a trained product application representative to ensure the total irradiance (UV dose) does not exceed recommended human exposure limits. To the extent UV solutions are combined, it may impact inactivation rates.
ATTEND THE WEBINAR
LEARN ABOUT DISINFECTION LIGHTING TECHNOLOGY AND CURRENT'S 365DISINFXTM SOLUTIONS.
Stay tuned. Webinars resuming in 2021.
Designed for Continuous Use in High Traffic Spaces
At education
At hospitals
At work
At healthcare spaces
At meeting places
At leisure
Make an Informed Decision
- UV radiation can pose a risk of personal injury. Overexposure can result in damage to eyes and bare skin. To reduce risk of overexposure, equipment must be installed in accordance with site planning and application recommendations.
- UV solutions are intended for common high traffic spaces and not recommended for dwellings or home use.
- Installation of the devices should be performed by qualified professionals as detailed in Current’s installation guide
- To allow for occupancy, Current products comply with IEC 62471 Photobiological Safety for Lamps and Lamp Systems standard and American Conference of American Hygienists (ACGIH®) TLVs®
- Current's UV products are meant to be used in conjunction with other protective measures like manual cleaning and the use of proper PPE. They are not a substitute for other measures.
- Current products are not intended to be used as a medical devices.
- When combining two or more UV solutions, whether from GE Current, a Daintree company and/or other manufacturers, please consult a trained product application representative to ensure the total irradiance (UV dose) does not exceed recommended human exposure limits. To the extent UV solutions are combined, it may affect the deactivation rates. To the extent UV solutions are combined, it may impact inactivation rates.
Voltage | Modules | Lumens | Color Temp. | Efficiency | CRI | Controls & Sensors | Additional Technolgy | |
UVA Tecnology Surface Disinfection Products | ||||||||
![]() LBU Series → Spec Sheet |
120V or 277V | 2x2 | 2,000-4,000 |
3500K |
Up to 81 LPW | 80 | 0-10V Dimming | 365DisInFx™ technology White Antimicrobial Paint |
![]() LBU Series → Spec Sheet |
120V or 277V | 2x4 | 2,000-6,000 | 3500K 4000K |
Up to 81 LPW | 80 | 0-10V Dimming | 365DisInFx™ technology White Antimicrobial Paint |
![]() LBU Series → Spec Sheet |
120V or 277V | 1x4 | 2,000-4,000 | 3500K 4000K |
Up to 81 LPW | 80 | 0-10V Dimming | 365DisInFx™ technology White Antimicrobial Paint |
![]() AVU Series → Spec Sheet |
120V or 277V | 4’ | 2,000-4,000 | 3500K 4000K |
Up to 100 LPW | 80 | 0-10V Dimming | 365DisinFx™ UVA Technology White Antimicrobial Paint |
![]() LDU Series → Spec Sheet |
120 or 277 | 6” Diameter | 1,000-4,000 | 3500K 4000K |
Up to 52 LPW | 80 | 0-10V Dimming | 365DisinFx™ UVA Technology White Antimicrobial Paint |
UVC Technology Air Disinfection Products | ||||||||
![]() LPU Series → Spec Sheet |
120 or 277 | 5” Diameter | N/A | N/A | N/A | N/A | N/A |
365DisinFx™ UVC Technology |
© 2020 Current Lighting Solutions, LLC. All rights reserved. GE and the GE monogram are trademarks of the General Electric Company and are used under license. Information provided is subject to change without notice. All values are design or typical values when measured under laboratory conditions.

Voltage: 120V or 277V
Modules: 2x2
Lumens: 2,000-4,000
Color Temp: 3500K, 4000K
Efficiency: Up to 81 LPW
CRI: 80
Controls & Sensors: 0-10V Dimming
Additional Technology: Current’s patented 365DisInFx™ technology, White Antimicrobial Paint

Voltage: 120V or 277V
Modules: 2x4
Lumens: 2,000-4,000
Color Temp: 3500K, 4000K
Efficiency: Up to 81 LPW
CRI: 80
Controls & Sensors: 0-10V Dimming
Additional Technology: Current’s patented 365DisInFx™ technology, White Antimicrobial Paint

Voltage: 120V or 277V
Modules: 1x4
Lumens: 2,000-4,000
Color Temp: 3500K, 4000K
Efficiency: Up to 81 LPW
CRI: 80
Controls & Sensors: 0-10V Dimming
Additional Technology: Current’s patented 365DisInFx™ technology, White Antimicrobial Paint
1. UVC Testing, Lab Results & Notes back to top
Current has completed in-situation testing with 365DisInFx™ UVC disinfection technology LPU Series devices on the aerosolized virus, bacteriophage MS2. Bacteriophage MS2 is a nonenveloped virus that is commonly used as a surrogate for viruses that are pathogenic to humans. Bacteriophage MS2 is generally understood to be more resistant than enveloped viruses (which include coronaviruses) to UVC.
The bacteriophage MS2 testing resulted in an 88% inactivation of the aerosolized virus in a 10’ x 10’ room in 4 hours.
Based on these bacteriophage MS2 results, Current predicts the continuous of operation of the 365DisInFx™ LPU will provide a 1-log reduction (90%) in less than 3 hours and a 2-log reduction (99%) in less than 6 hours for seasonal coronaviruses and SARS-CoV-2 in a typical room application.
2. UVA Testing, Lab Results & Notes back to top
365DisInFx™ UVA disinfection technology was tested using in-vitro methods as described in detail in Citations 1 & 2 below (Livingston, Kvam) which resulted in 99.7% reduction in MRSA on surfaces exposed to 3W/m2 of 365nm UVA over a single 8-hour period. Results of this testing demonstrated significant reduction over a similar exposure period of certain common pathogens including MRSA, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Candida albicans and auris, associated with Hospital Acquired Infections (HAIs). Photobiological science and mathematical modeling enables us to calculate expected inactivation rates for 24-hour continuous operation of the 365DisInFx™ UVA technology.
Notes & Citations:
1 Livingston SH, Cadnum JL, Benner KJ, Donskey CJ (2020) Efficacy of an ultraviolet-A lighting system for continuous decontamination of health care-associated pathogens on surfaces. Am. J. Infect. Control 48: 337-339.
https://doi.org/10.1016/j.ajic.2019.08.003
- inoculated steel disk carriers, modification of ASTM E-2197-02
- using a benchtop device that delivered the 3W/m² irradiance
2 Kvam E, Benner K (2017) Disinfection via LED Lighting: summary of mechanism and results for 365nm-mediated inactivation of microbes. GE Global Research Technical Information Series 2017GRC0545, GE Confidential (Class 3)
Kvam E, Benner K. Mechanistic insights into UV-A mediated bacterial disinfection via endogenous photosensitizers. Journal of Photochemistry and Photobiology B: Biology. 2020;209:111899. doi:10.1016/j.jphotobiol.2020.111899.
- aqueous cultures were diluted in sterile water and dried onto hydrophilic glass slides
- using a benchtop device that delivered the 3W/m² irradiance
Supporting Literature and Publications
Continuous Disinfecting: The Future of Fighting Hospital Acquired Infections
Fierce Electronics
Mechanistic insights into UV-A mediated bacterial disinfection via endogenous photosensitizers
Journal of Photochemistry and Photobiology B: Biology
American Journal of Infection Control | Brief Report
SHEA Spring 2018 Conference; April 18-20, 2018 | Portland, OR | Livingston S, Cadnum J, Nerandzic M, Donskey CJ